Oliver Ast

Person

Bassersdorf, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibodies against CD3EPSILON and ROR1
- Patent number 11,952,421
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 11,130,822
- Issue date Sep 28, 2021
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 11,117,965
- Issue date Sep 14, 2021
- HOFFMANN-LA ROCHE INC.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 11,111,312
- Issue date Sep 7, 2021
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the selection of antibodies against BCMA
- Patent number 10,851,171
- Issue date Dec 1, 2020
- ENGMAB SÀRL
- Minh Diem Vu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Monoclonal antibodies against BCMA
- Patent number 10,683,369
- Issue date Jun 16, 2020
- ENGMAB SÀRL
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,611,840
- Issue date Apr 7, 2020
- Hoffman-La Roche Inc.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,611,841
- Issue date Apr 7, 2020
- HOFFMANN-LA ROCHE INC.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 10,323,098
- Issue date Jun 18, 2019
- Roche GlycArt AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 10,316,104
- Issue date Jun 11, 2019
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies against CD3ϵ and BCMA
- Patent number 10,253,104
- Issue date Apr 9, 2019
- ENGMAB AG
- Minh Diem Vu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates
- Patent number 10,202,464
- Issue date Feb 12, 2019
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 10,184,009
- Issue date Jan 22, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3 and BCMA
- Patent number 10,077,315
- Issue date Sep 18, 2018
- ENGMAB SÀRL
- Minh Diem Vu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the selection of antibodies against BCMA
- Patent number 9,963,513
- Issue date May 8, 2018
- ENGMAB SÀRL
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 9,914,776
- Issue date Mar 13, 2018
- HOFFMANN-LA ROCHE INC.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates
- Patent number 9,447,159
- Issue date Sep 20, 2016
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant interleukin-2 polypeptides
- Patent number 9,266,938
- Issue date Feb 23, 2016
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20250043028
- Publication date Feb 6, 2025
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240425616
- Publication date Dec 26, 2024
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240141044
- Publication date May 2, 2024
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20230340160
- Publication date Oct 26, 2023
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST BCMA
- Publication number 20230322957
- Publication date Oct 12, 2023
- ENGMAB SARL
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20230287118
- Publication date Sep 14, 2023
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20220403027
- Publication date Dec 22, 2022
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20220242971
- Publication date Aug 4, 2022
- Roche Glycart AG
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA
- Publication number 20210070873
- Publication date Mar 11, 2021
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST BCMA
- Publication number 20200283545
- Publication date Sep 10, 2020
- ENGMAB SARL
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1
- Publication number 20200255521
- Publication date Aug 13, 2020
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20200231673
- Publication date Jul 23, 2020
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST BCMA
- Publication number 20190352427
- Publication date Nov 21, 2019
- ENGMAB SARL
- Minh Diem Vu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20190322763
- Publication date Oct 24, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20190322765
- Publication date Oct 24, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20190315883
- Publication date Oct 17, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20190077881
- Publication date Mar 14, 2019
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD3XROB04 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20180282410
- Publication date Oct 4, 2018
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20180273643
- Publication date Sep 27, 2018
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20180222981
- Publication date Aug 9, 2018
- HOFFMANN-LA ROCHE INC.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20180222980
- Publication date Aug 9, 2018
- HOFFMANN-LA ROCHE INC.
- Oliver Ast
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA
- Publication number 20180222991
- Publication date Aug 9, 2018
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20180142037
- Publication date May 24, 2018
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA
- Publication number 20170327579
- Publication date Nov 16, 2017
- ENGMAB AG
- MINH DIEM VU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TR...
- Publication number 20170306044
- Publication date Oct 26, 2017
- MINH DIEM VU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1
- Publication number 20170306018
- Publication date Oct 26, 2017
- MINH DIEM VU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA
- Publication number 20170306036
- Publication date Oct 26, 2017
- ENGMAB AG
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20170088631
- Publication date Mar 30, 2017
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1
- Publication number 20160297881
- Publication date Oct 13, 2016
- ENGMAB AG
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IMMUNOCONJUGATES
- Publication number 20160263240
- Publication date Sep 15, 2016
- Roche Glycart AG
- Oliver Ast
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bispecific antibodies against CD3EPSILON and ROR1

Immunoconjugates

Bispecific T cell activating antigen binding molecules

Mutant interleukin-2 polypeptides

Method for the selection of antibodies against BCMA

Monoclonal antibodies against BCMA

Bispecific T cell activating antigen binding molecules

Bispecific T cell activating antigen binding molecules

Mutant interleukin-2 polypeptides

Immunoconjugates

Bispecific antibodies against CD3ϵ and BCMA

Immunoconjugates

Mutant interleukin-2 polypeptides

Bispecific antibodies against CD3 and BCMA

Method for the selection of antibodies against BCMA

Bispecific T cell activating antigen binding molecules

Immunoconjugates

Mutant interleukin-2 polypeptides

Patents Applicationslast 30 patents

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

MONOCLONAL ANTIBODIES AGAINST BCMA

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

NOVEL IMMUNOCONJUGATES

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

MONOCLONAL ANTIBODIES AGAINST BCMA

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

MONOCLONAL ANTIBODIES AGAINST BCMA

NOVEL IMMUNOCONJUGATES

MUTANT INTERLEUKIN-2 POLYPEPTIDES

NOVEL IMMUNOCONJUGATES

MUTANT INTERLEUKIN-2 POLYPEPTIDES

ANTI-CD3XROB04 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

MUTANT INTERLEUKIN-2 POLYPEPTIDES

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TR...

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

NOVEL IMMUNOCONJUGATES

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1

NOVEL IMMUNOCONJUGATES